expression revealed suppression in the relative fold change of IL-6 by 23%, IL-8 by 30%, TNF-α by 11%, and IFN-γ by 21% with Tai Chi. Conclusions: These data suggest that moderate exercise and stress management can have potent immunoregulatory effects on the chronic, systemic inflammation associated with SLE and identify daily Tai Chi exercise as a viable adjunct therapy to compliment current pharmacological interventions. 
Unpaired T test performed; **p<0.01, n = total number, % percentage, IQR = interquartile range, ethnicity: C = Caucasian, A = Asian, MN = African Caribbean, O = Chinese, anti-Ro = antiSjögren's-syndrome-related antigen A, anti-La = anti-Sjögren's-syndrome-related antigen B.
We found significant correlations of SSDDI score with disease duration and maximum ESSDAI score in patients with pSS (r=0.27, p=0.05 and r=0.67, p=0.0001, respectively). In SLE/SS patients, ESSPRI scores correlated with both BILAG and maximum ESSDAI score (r=0.55, p=0.03 and r=0.7, p=0.02, respectively). The SSDDI score correlated with the disease duration only in pSS patients (r=0.27, p=0.05). Conclusions: Our study showed that there was no similar correlation between various disease scores in patients with pSS compared to SLE/SS patients. If the patient reported outcomes correlated with the disease activity (ESSDAI and BILAG) in SLE/SS patients, this correlation was not seen in pSS patients, in which the significant correlations were found only between damage scores, highest disease activity score and disease duration. 
AB0153 DELETION OF RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) DOES NEITHER AFFECT AUTO-ANTIBODY PRODUCTION NOR DEVELOPMENT OF RENAL DISEASE IN PRISTANE-INDUCED LUPUS

N. Chevalier, R. Rzepka, R. Voll. University Freiburg Medical Center, Freiburg, Germany
Background: Systemic lupus erythematosus (SLE) is characterized by autoantibodies to diverse autoantigens, especially to nuclear components such as double-stranded DNA (dsDNA) or nucleosomes. Still, it remains unclear why poorly immunogenic molecules such as dsDNA and nucleosomes become targets of humoral autoimmunity in SLE. Increased signaling via pattern-recognition receptors (PRRs) through pathogen-associated molecular patterns (PAMPs) or endogenous damage-associated molecular patterns (DAMPs) released from damaged or stressed host cells and tissues, may be critically involved in the break of tolerance against such nuclear antigens. One important PRR in this context may be RAGE. Among many others, RAGE recognizes High mobility group box 1 (HMGB1). HMGB1 is a DNA-binding nuclear protein that has been found at elevated levels in patients with SLE and other autoimmune diseases; likewise perpetuation of RAGE signaling sustains inflammation and leads to the establishment of chronic inflammatory disorders. Objectives: We therefore examined, using the Pristane-induced SLE model, if increased RAGE signaling may be involved in the break of tolerance against nuclear antigens and contributes to chronic inflammation. Methods: To that end, WT and RAGE-/-animals were injected intra-peritoneally with a single dose of pristane. Disease manifestations were determined after 7 months and included the determination of proteinuria and renal pathology by evaluating the glomerular cellularity and matrix on H&E stained paraffinembedded kidney sections and glomerular depositions of IgG and C3c. In addition to that we checked for auto-antibody production at several time points during disease development and immune cell distribution, differentiation and phenotype in inflamed kidneys and spleen. Background: In systemic lupus erythematosus (SLE), lupus nephritis (LN) is associated with chronic inflammation and perpetuated fibroblast activation, both determined by epigenetic mechanisms involving aberrant CpG DNA promoter methylation. During SLE progression, global methylation patterns are commonly lost. These CpG DNA promoter methylation patterns are not limited to the kidney, circulating CpG-rich DNA is also detectable in the blood allowing for biomonitoring ("liquid biopsy"). However, little is known about its specific contribution to determining disease progression. In the kidney, CpG-rich DNA activates TLR9 signaling mechanisms involved in inflammation and fibrogenesis. Based on these observations, we hypothesized that CpG-rich DNA promoter fragments potentially accelerate renal inflammation and fibrogenesis in SLE-associated LN. Objectives: To analyze the role of circulating CpG-rich DNA on endothelial TLR9 signalling and the effect of experimental modification of oligodinucleotides on kidney inflammation in the Pristane-induced murine model of SLE. Methods: We isolated circulating CpG-rich DNA from blood samples in a cohort of SLE patients. Then, we tested how these DNA promoter fragments influenced the LN phenotype in a TMPD ("pristane")-induced mouse model. Further, we investigated how this renal response could be influenced by the administration of either human or synthetic methylated/unmethylated CpGrich DNA oligodinucleotides. Additionally, the effects of the administration of cicruclating CpG-rich DNA fragments on TLR9-signalling was analyzed in endothelial cell cultures. Results: We show that circulating CpG-rich DNA promoter fragments are detectable in SLE patients' blood. Furthermore, SLE-associated LN is associated with accumulation of unmethylated CpG-rich DNA promoter fragments, implicating a mechanistic connection. These observations were further corroborated in a rodent model of TMPD-induced SLE where administration of CpG-rich DNA (isolated from LN patients or synthetic unmethylated CpG-rich DNA oligonucleotides) worsened the renal phenotype in terms of inflammation and fibrogenesis. Causal contribution of TLR9 was further confirmed in Tlr9 +/--knockout mice with protection from renal inflammation and kidney fibrosis after administration of unmethylated CpG-rich DNA promoter oligonucleotides. TLR9-mediated intrarenal
